Schepis, Ty S.Werner, KennedyFigueroa, OliviaMcCabe, Vita V.Schulenberg, JohnVeliz, Philip T.Wilens, Timothy E.McCabe, Sean Esteban2023-05-102023-05-102023-04Schepis, T. S., Werner, K. S., Figueroa, O., McCabe, V. V., Schulenberg, J. E., Veliz, P. T., Wilens, T. E., & McCabe, S. E. (2023). Type of medication therapy for ADHD and stimulant misuse during adolescence. Poster presented at the Health Scholar Showcase, Translational Health Research Center, San Marcos, Texas.https://hdl.handle.net/10877/16768Adolescent attention-deficit/hyperactivity disorder (ADHD) diagnosis rates increased from 18% to 33% in the USA from 1999 to 2016. Fairman et al. found a 15.6% increase in stimulant prescribing to youth from 2008/09 to 2012/13, and nonstimulant prescribing is 10-15% of all therapy. Attention-deficit/hyperactivity disorder (ADHD) is associated with higher substance use rates, including prescription stimulant misuse (PSM), cocaine use, and methamphetamine use. Stimulant and non-stimulant pharmacotherapy improve adolescent ADHD, but their associations with PSM, cocaine, and methamphetamine use are unclear. Using 2005–2020 US Monitoring the Future (MTF) data, we investigated relationships between ADHD pharmacotherapy history and PSM, cocaine, or methamphetamine use.Image1 page1 file (.pdf)enmedication therapystimulant misuseadolescent attention-deficit hyperactivity disorderADHDPoster